April McDonald, MD
Critical Care Medicine · Gainesville, GANPI 1275892440
Payments from drug & device makers
What this record shows
This record is dominated by education: $28,016 of the $40,819 with a category attached, or 68.6%. Intuitive Surgical accounts for 97.3% of it on its own, with 13 other manufacturers making up the rest. 2025 is the largest year on record at $34,350, more than ten times the $36 reported in 2021. Among critical care medicine clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 98 payments — averaging $416.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$40K
- GSK$422
- Olympus America Inc.$189
- Pulmonx Corporation$168
- Pinnacle Biologics, Inc$61
- Boehringer Ingelheim$61
- plus $191 from 8 others
What the payments were for
- Speaking & faculty fees$5,50013%
- Travel & lodging$2,6426%
- Food & beverage$4,63811%
- Education$28,01669%
- Gifts$230%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 53 | $39,727 |
| GSK | 28 | $422 |
| Olympus America Inc. | 4 | $189 |
| Pulmonx Corporation | 1 | $168 |
| Pinnacle Biologics, Inc | 1 | $61 |
| Boehringer Ingelheim | 2 | $61 |
| AstraZeneca | 2 | $46 |
| Sanofi | 1 | $29 |
| Actelion Pharmaceuticals US, Inc. | 1 | $25 |
| AbbVie | 1 | $23 |
| Mylan Specialty L.p. | 1 | $20 |
| Ambu Inc. | 1 | $18 |
| Insmed, Inc. | 1 | $16 |
| Merit Medical Systems Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$40,819 in reported general payments places this provider in the 95th percentile of 265 critical care medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 268 | $236,082 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 198 | $145,520 |
| Breo ElliptaFluticasone/Vilanterol | 45 | $26,181 |
| Advair HfaFluticasone Propion/Salmeterol | 59 | $22,950 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 33 | $19,411 |
| Spiriva RespimatTiotropium Bromide | 26 | $16,765 |
| Wixela InhubFluticasone Propion/Salmeterol | 50 | $9,125 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 61 | $8,467 |
| Spiriva HandihalerTiotropium Bromide | 15 | $8,279 |
| Bevespi AerosphereGlycopyrrolate/Formoterol Fum | 16 | $6,793 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 14 | $6,761 |
| Incruse ElliptaUmeclidinium Bromide | 18 | $5,981 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 181 | $5,237 |
| SymbicortBudesonide/Formoterol Fumarate | 22 | $4,921 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 19 | $3,536 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Incruse Ellipta | $422 | $287,656364 claims |
| AstraZenecaBreztri Aerosphere, Bevespi Aerosphere, Symbicort | $46 | $157,234236 claims |
| Boehringer IngelheimSpiriva Respimat, Stiolto Respimat | $61 | $23,52740 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 265 critical care medicine providers in Georgia.
Other critical care medicine in Gainesville
- Usha NayakGainesville$4K
- Joe ClementsGainesville$3K
- Salman FidahusseinLagrange$852K
- Bruce FriedmanAugusta$629K
- Gregory MauldinSnellville$221K
- Ramzy RimawiAtlanta$72K
- Rafael Alba YunenBrunswick$58K
- Matthew SchmittAtlanta$32K
- Prasad GarimellaBraselton$20K
- James PalazzoloAlbany$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.